Carmat SA (EPA: ALCAR)
France
· Delayed Price · Currency is EUR 1.102
-0.048 (-4.17%)
Dec 3, 2024, 4:16 PM CET
Carmat Revenue
Carmat had revenue of 3.65M EUR in the half year ending June 30, 2024, with 2,795.24% growth. This brings the company's revenue in the last twelve months to 6.93M, up 661.10% year-over-year. In the year 2023, Carmat had annual revenue of 3.84M with 704.40% growth.
Revenue (ttm)
6.93M
Revenue Growth
+661.10%
P/S Ratio
5.83
Revenue / Employee
42.75K
Employees
182
Market Cap
48.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.84M | 3.36M | 704.40% |
| Dec 31, 2022 | 477.00K | -1.76M | -78.68% |
| Dec 31, 2021 | 2.24M | 2.23M | 24,755.56% |
| Dec 31, 2020 | 9.00K | -5.00K | -35.71% |
| Dec 31, 2019 | 14.00K | - | - |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |